Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer.
复制标题
DOI:
10.1371/journal.pone.0044488
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Takata T
中科院分区:
文献类型:
--
作者:
Kudo Y;Iizuka S;Yoshida M;Nguyen PT;Siriwardena SB;Tsunematsu T;Ohbayashi M;Ando T;Hatakeyama D;Shibata T;Koizumi K;Maeda M;Ishimaru N;Ogawa I;Takata T
Metastasis to regional lymph nodes via lymphatic vessels plays a key role in cancer progression. Tumor lymphangiogenesis is known to promote lymphatic metastasis, and vascular endothelial growth factor C (VEGF-C) is a critical activator of tumor lymphangiogenesis during the process of metastasis. We previously identified periostin as an invasion- and angiogenesis-promoting factor in head and neck squamous cell carcinoma (HNSCC). In this study, we discovered a novel role for periostin in tumor lymphangiogenesis. Periostin overexpression upregulated VEGF-C mRNA expression in HNSCC cells. By using conditioned media from periostin-overexpressing HNSCC cells, we examined tube formation of lymphatic endothelial cells. Conditioned media from periostin-overexpressing cells promoted tube formation. To know the correlation between periostin and VEGF-C, we compared Periostin expression with VEGF-C expression in 54 HNSCC cases by immunohistochemistry. Periostin expression was correlated well with VEGF-C expression in HNSCC cases. Moreover, correlation between periostin and VEGF-C secretion was observed in serum from HNSCC patients. Interestingly, periostin itself promoted tube formation of lymphatic endothelial cells independently of VEGF-C. Periostin-promoted lymphangiogenesis was mediated by Src and Akt activity. Indeed possible correlation between periostin and lymphatic status in periostin-overexpressing xenograft tumors and HNSCC cases was observed. Our findings suggest that periostin itself as well as periostin-induced upregulation of VEGF-C may promote lymphangiogenesis. We suggest that periostin may be a marker for prediction of malignant behaviors in HNSCC and a potential target for future therapeutic intervention to obstruct tumoral lymphatic invasion and lymphangiogenesis in HNSCC patients.
登录
查看更多内容
影响因子:
64.5
作者:
BROOKS, PC;MONTGOMERY, AMP;CHERESH, DA
通讯作者:
CHERESH, DA
影响因子:
4
作者:
Litvin, J;Selim, AH;Safadi, FF
通讯作者:
Safadi, FF
DOI:
10.1073/pnas.95.24.14389
发表时间:
1998-11-24
影响因子:
11.1
作者:
Cao, YH;Linden, P;Alitalo, K
通讯作者:
Alitalo, K
影响因子:
9.7
作者:
Bai, Yanhua;Kakudo, Kennichi;Zhou, Gengyin
通讯作者:
Zhou, Gengyin
影响因子:
50.3
作者:
Bao, SD;Ouyang, G;Wang, XF
通讯作者:
Wang, XF